{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:08:05Z","timestamp":1761829685772,"version":"build-2065373602"},"reference-count":3,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jfma.2024.12.037","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:25:13Z","timestamp":1736205913000},"page":"1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to Comment on \u201cFibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis C\u2033"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-7941","authenticated-orcid":false,"given":"Tung-Hung","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2024.12.037_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jfma.2024.06.008","article-title":"Fibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis C","volume":"123","author":"Chang","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2024.12.037_bib2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/hepr.13932","article-title":"Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months","volume":"53","author":"Su","year":"2023","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jfma.2024.12.037_bib3","doi-asserted-by":"crossref","unstructured":"Liu C.H., Cheng P.N., Fang Y.J., Chen C.Y., Kao W.Y., Lin C.L., et al. Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection. J Hepatol 2024;S0168-8278(24)02578-9. doi: 10.1016\/j.jhep.2024.09.038. Online ahead of print.","DOI":"10.1016\/j.jhep.2024.09.038"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624006168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624006168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:03:11Z","timestamp":1761829391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664624006168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":3,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0929664624006168"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.12.037","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to Comment on \u201cFibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis C\u2033","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}